KIR2DL3 antibody (AA 19-161)

Catalog No. ABIN165424

This Mouse Monoclonal antibody specifically detects KIR2DL3 in WB, ELISA, IF and ICC. It exhibits reactivity toward Human.

Quick Overview for KIR2DL3 antibody (AA 19-161) (ABIN165424)

Target: KIR2DL3 (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This KIR2DL3 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone: 190IIC311

Product Details anti-KIR2DL3 Antibody

Binding Specificity: AA 19-161

Purpose: Human CD158b2/KIR2DL3 antibody

Purification: Purified

Immunogen: Recombinant human KIR2DL3 (19-161aa) purified from E. coli

Isotype: IgG2a kappa

Application Details

Application Notes: Recommended dilution 1:1000(W.B), (FACS)

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing cycles

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Target Details for KIR2DL3

Target: KIR2DL3 (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))

Alternative Name: CD158b2/KIR2DL3

Background: Reacts with extracellular domain of the KIR2DL3, a member of the Killer cell immunoglobulin-liKe receptor(KIR) family. The KIR family consists of transmembrane glycoproteins of the Ig superfamily expressed on human NK cells and a subset of human T cells which they are involved in recognition of either MHC class I molecules or unKnown ligand on target cells and inhibit cytotoxic activities.

NCBI Accession: NP_055326

Pathways: Cancer Immune Checkpoints